REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 39
08/03/2016 12:10
- Part 39: For the preceding part double click ID:nRSH4027RL
their debts through, for example, the issuance of government bonds which
might trade at a discount to the face value of the debt.In addition, our
customers may cease to trade, which may result in losses from writing off
debts, or the sustained economic downturn may unfavourably affect the
spending patterns of the consumers of our products.We are highly
dependent on being able to access a sustainable flow of liquid funds due
to the high fixed costs of operating our business and the long and
uncertain development cycles of our products. In a sustained economic
downturn, financial institutions with whom we deal may cease to trade and
there can be no guarantee that we will be able to access monies owed to
us without a protracted, expensive and uncertain process, if at all.More
than 95% of our cash investments are managed centrally and are invested
- More to follow, for following part double click ID:nRSH4027RNRecent news on AstraZeneca
See all newsREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementRCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement